Nearly all reported cases of hemangioblastomas are in the CNS, and extraneural locations are extremely rare. Specifically, intraosseous hemangioblastomas are rarely seen. There have been only 2 case reports in the literature on this condition over the last 20 years. 3, 9 Due to their location in bone, hemangioblastomas may be a confounding diagnosis to make, particularly in patients with a known primary malignancy. In patients with no known malignancy, the nonspecific imaging findings may prompt a malignancy workup. To our best knowledge, there have been no described cases of intraosseous hemangioblastomas in the cervical vertebrae. In this report, we describe a case of pathological cervical vertebral fracture secondary to a sporadic, intraosseous hemangioblastoma. We believe that the rarity of its location, unique clinical presentation, nonspecific imaging findings, and subsequent treatment improve our understanding of this rare tumor, the diversity of its presentation, and its management strategy.
Case Report

History
A 69-year-old woman presented to our institution with a 2-week history of worsening bilateral upper-extremity pain after a mechanical fall. She initially presented to an urgent care center, where she was given a neck brace and discharged home on naproxen and prednisone. However, her pain worsened. On presentation, she described sharp, intractable pain radiating down the lateral aspect of her arms in the C-5 dermatomal distribution with minimal neck motion.
Physical Examination
She appeared comfortable in a Miami cervical collar. Her cranial nerve examination revealed left tongue deviation, in keeping with her known history of radiation-treated left vagal nerve schwannoma. The remainder of her neurological examination showed intact status, except 4/5 motor strength in bilateral shoulder abduction.
Neuroimaging
A cervical spine CT demonstrated an approximately 25% loss of height of the C-4 vertebral body, which was largely replaced by soft tissue with no visible internal trabeculae (Fig. 1) . Subsequent MRI showed abnormal marrow replacement and enhancement throughout the C-4 vertebral body and posterior elements, sparing the spinous process. Additionally, enhancing soft tissues were present in the prevertebral ventral epidural space, and in the bilateral neural and transverse foramina at the C-4 level, resulting in mild central stenosis. Expansile tumor was spread within the pedicles and facets, obliterating the neural foramina. At this time, the primary radiological differential considerations were metastasis and plasmacytoma.
However, metastatic workup was negative. A CTguided biopsy was performed and showed vascular tumor within bone, consistent with intraosseous hemangioblastoma. Given this diagnosis, selective angiograms were performed for preoperative vascular evaluation and tumor embolization (Fig. 2) . Feeding arteries were identified from the muscular branches of V 2 segments of the vertebral arteries and thyrocervical trunks. Robust feeders were seen from the thyrocervical trunks and were superselectively embolized with Onyx 18.
Operation
The patient underwent a C-4 corpectomy with C3-5 anterior and posterior instrumented fusion. Intraoperatively, the longus colli muscles at the C-4 level were infiltrated and hypervascular. The C-4 vertebral body was comminuted.
Pathological Findings
Macroscopically, a CT-guided core biopsy of the C-4 vertebral body showed 2 fragments of red-pink rubbery soft tissues. Microscopic analysis of the specimens demonstrated that the lesion was within bone and was vasoformative, with a dual population of cells (Fig. 3 ). Specimen staining with inhibin was noncontributory. Staining with CD56 and neuron-specific enolase (NSE) was positive in foamy cells. Staining with erythroblast transformationspecific-related gene (ERG), CD31, and CD34 was positive in endothelial cells. Staining with MelanA, CD10, AE1/AE3, Cam 5.2, epithelial membrane antigen (EMA), and human herpes virus (HHV)-8 was negative. The Ki-67 level was low. Immunohistochemical profile confirmed the vascular nature of the lesion and did not support metastatic carcinoma or plasmacytoma. These findings were consistent with intraosseous hemangioblastoma. Pathological analysis of the surgical specimens confirmed WHO Grade I hemangioblastoma within bone. At this time, immunohistochemistry for inhibin was positive, further supporting this diagnosis.
Postoperative Course
At the 1-year follow-up, CT and MR images of the cervical spine showed the spinal cord decompressed with residual tumor lateral to the construct, which was unchanged from immediate postoperative imaging (Fig. 4) . At the 1-year point, the patient had done exceptionally well. She was without neck pain and her upper-extremity pain had completely resolved.
Discussion
The differential diagnosis of a lytic lesion with bone marrow replacement and diffuse enhancement in a cervical vertebra is broad. 16 However, given the patient's age, the most common etiologies are metastasis, myeloma, and-rarely-atypical hemangiomas. Atypical hemangiomas are rarely completely lucent on CT scans; they typically have vertical internal trabeculae and no diffusion restriction on diffusion-weighted imaging. 8 Intracranial hemangioblastomas are described as cystic lesions with solid enhancing intramural nodules. Their MR characteristics are hypo-or isointense on T1-weighted imaging and hyperintense on T2-weighted imaging. 2, 11 Due to high vascularity, these tumors typically demonstrate avid, diffuse enhancement and may show vascular flow voids on unenhanced images.
The prevalence of osseous hemangioblastomas is unknown. There have been only 2 reported cases in the last 20 years. 3, 9 In one example, Cho and colleagues reported a case of sporadic osseous hemangioblastoma in a thoracic vertebra, which was initially suspected to be a metastasis on imaging in a patient with a history of renal cell carcinoma. 3 Given its unusual location, this type of intraosseous tumor can only be suggested as a diagnosis of exclusion prior to biopsy. Our case demonstrated avid enhancement indicative of a highly vascular tumor. However, this is a rather nonspecific feature of hemangioblastomas. Often, there are overlapping imaging features between this rare tumor and other much more common etiologies, such as metastasis, myeloma, and lymphoma. Even with clinical and imaging findings raising suspicion, the diagnosis can only be made with pathological analysis.
There is no clear guideline for the management of intraosseous hemangioblastomas. Treatments similar to those used for its counterparts within the neuraxis were performed in the reported cases. 3 Anatomical location of the tumor is an important factor in determining the therapeutic approach. Small or asymptomatic tumors may be followed with imaging to ensure stability, until they become enlarged or symptomatic. 18, 19 There are 2 treatment modalities available for intraaxial hemangioblastomas: resection and radiation therapy. For solitary tumors in surgically accessible locations, surgical removal often offers definitive treatment with acceptable postoperative morbidities. 7, 12, 13, 19, 20 Due to the highly vascular nature of these tumors, surgery is typically supplemented by preoperative embolization, which minimizes intraoperative blood loss and allows for complete resection of the tumor using a microdissection technique. 1, 5, 6, 17 On the other hand, radiation therapy is considered a feasible alternative for surgically inaccessible lesions or VHL-related, multifocal lesions. 3, 10, 14 Regardless of treatment modality, the primary goal of therapy is to avoid treatment-related morbidities. This patient became symptomatic after pathological fracture of a cervical vertebra secondary to intravertebral hemangioblastoma. Fortunately for her, the hemangioblastoma was extradural and intravertebral in location, which allowed complete resection with no significant complications.
Conclusions
Intraosseous hemangioblastoma should be considered in the differential diagnosis of isolated intravertebral low-density lesions with marrow replacement and avid enhancement, after common etiologies are excluded. In reporting this case, we illustrate the diversity of presentation of hemangioblastomas and the effective management techniques of this rare tumor in an extremely rare location.
